Word: clots
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...voiced, blue-eyed man became the first American cardinal ever appointed to the powerful Roman Curia. But when he arrived in April to take up his duties as Proprefect of the Vatican's Sacred Congregation for the Propagation of the Faith, he was a stricken man. A blood clot forced the amputation of his right arm (TIME, May 5). On the mend, he was felled by a stroke, later complicated by heart disease. Last week at 70. and at the peak of a brilliant career, Samuel Cardinal Stritch died...
...Stritch was rushed to Sanatrix Clinic. Telegrams poured in from all over the world. To consult with the Italian doctors, two U.S. physicians flew to Rome without waiting to get their passports in order. At the Cardinal's bedside, they concurred in the diagnosis: a block-probably a clot-in a major artery of his right arm. This week the doctors agreed on a drastic recourse: amputation of the Cardinal...
Arthur D. Schulte, son of the developer of the Schulte national chain of cigar stores, was making rapid strides in his father's footsteps when, at 32, he fell ill with thrombophlebitis-inflammation of leg veins, with formation of clots that could be fatal if they reached the lungs. That was 20 years ago. Schulte's physician, Dr. Irving Wright, casting around for a drug to prevent clot formation (none had yet been proved effective in man), appealed to Nobel Prizewinner Charles H. Best, co-discoverer of insulin. He wanted some of the heparin that University of Toronto...
From Rotten Clover. Heparin has had a distinguished history since Schulte's early case, has proved invaluable in a variety of conditions where clotting is a danger, notably after a patient has already had a heart attack or stroke from a thrombus (clot). Heparin's advantage over most rival anticlotting drugs: it acts immediately. Its disadvantages: it is expensive and must be injected under the skin or infused into a vein...
...more dismayed by the sensational stories than Dr. Mario Stefanini of Boston's St. Elizabeth's Hospital, who had worked for two years to get the extract (an enzyme) from common molds. He has found that it dissolves the fibrous part of clots in animals and has tested its safety in 25 humans. But it will be two years, he estimates, before its value in relieving the symptoms of heart attacks and strokes can be shown. In any case it cannot reverse the original damage done by the clot. There is no assurance that the extract...